nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Mercaptopurine—hematologic cancer	0.111	0.178	CbGbCtD
Zaleplon—AOX1—Methotrexate—hematologic cancer	0.0364	0.0581	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0232	0.0371	CbGbCtD
Zaleplon—CYP3A7—Ifosfamide—hematologic cancer	0.0232	0.0371	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0222	0.0355	CbGbCtD
Zaleplon—CYP3A7—Imatinib—hematologic cancer	0.0222	0.0355	CbGbCtD
Zaleplon—CYP3A5—Daunorubicin—hematologic cancer	0.0217	0.0347	CbGbCtD
Zaleplon—CYP3A5—Thalidomide—hematologic cancer	0.0198	0.0316	CbGbCtD
Zaleplon—CYP3A5—Teniposide—hematologic cancer	0.0189	0.0302	CbGbCtD
Zaleplon—CYP3A5—Ifosfamide—hematologic cancer	0.0174	0.0278	CbGbCtD
Zaleplon—CYP3A5—Imatinib—hematologic cancer	0.0167	0.0266	CbGbCtD
Zaleplon—CYP3A4—Bexarotene—hematologic cancer	0.0145	0.0231	CbGbCtD
Zaleplon—CYP3A7—Irinotecan—hematologic cancer	0.0139	0.0222	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0139	0.0222	CbGbCtD
Zaleplon—CYP3A4—Busulfan—hematologic cancer	0.0134	0.0215	CbGbCtD
Zaleplon—CYP3A4—Lomustine—hematologic cancer	0.0134	0.0215	CbGbCtD
Zaleplon—CYP3A5—Dasatinib—hematologic cancer	0.0134	0.0214	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0121	0.0194	CbGbCtD
Zaleplon—CYP3A7—Vincristine—hematologic cancer	0.0121	0.0194	CbGbCtD
Zaleplon—CYP3A4—Thiotepa—hematologic cancer	0.012	0.0191	CbGbCtD
Zaleplon—CYP3A5—Irinotecan—hematologic cancer	0.0104	0.0166	CbGbCtD
Zaleplon—CYP3A4—Methoxsalen—hematologic cancer	0.00932	0.0149	CbGbCtD
Zaleplon—CYP3A7—Dexamethasone—hematologic cancer	0.00913	0.0146	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00913	0.0146	CbGbCtD
Zaleplon—CYP3A5—Vincristine—hematologic cancer	0.00909	0.0145	CbGbCtD
Zaleplon—CYP3A4—Bortezomib—hematologic cancer	0.00886	0.0142	CbGbCtD
Zaleplon—CYP3A4—Daunorubicin—hematologic cancer	0.00848	0.0135	CbGbCtD
Zaleplon—CYP3A5—Etoposide—hematologic cancer	0.00833	0.0133	CbGbCtD
Zaleplon—CYP3A4—Cytarabine—hematologic cancer	0.00748	0.0119	CbGbCtD
Zaleplon—CYP3A4—Teniposide—hematologic cancer	0.00737	0.0118	CbGbCtD
Zaleplon—CYP3A5—Dexamethasone—hematologic cancer	0.00685	0.0109	CbGbCtD
Zaleplon—CYP3A4—Ifosfamide—hematologic cancer	0.0068	0.0109	CbGbCtD
Zaleplon—CYP3A4—Imatinib—hematologic cancer	0.00649	0.0104	CbGbCtD
Zaleplon—CYP3A4—Ruxolitinib—hematologic cancer	0.00612	0.00977	CbGbCtD
Zaleplon—CYP3A4—Nilotinib—hematologic cancer	0.0059	0.00943	CbGbCtD
Zaleplon—CYP3A4—Vinorelbine—hematologic cancer	0.00585	0.00935	CbGbCtD
Zaleplon—CYP3A4—Triamcinolone—hematologic cancer	0.00535	0.00855	CbGbCtD
Zaleplon—CYP3A4—Dasatinib—hematologic cancer	0.00522	0.00833	CbGbCtD
Zaleplon—CYP3A4—Mitoxantrone—hematologic cancer	0.00515	0.00823	CbGbCtD
Zaleplon—CYP3A4—Betamethasone—hematologic cancer	0.00459	0.00734	CbGbCtD
Zaleplon—CYP3A4—Prednisolone—hematologic cancer	0.00453	0.00724	CbGbCtD
Zaleplon—CYP3A4—Prednisone—hematologic cancer	0.00428	0.00684	CbGbCtD
Zaleplon—CYP3A4—Irinotecan—hematologic cancer	0.00406	0.00648	CbGbCtD
Zaleplon—CYP3A4—Vinblastine—hematologic cancer	0.00361	0.00576	CbGbCtD
Zaleplon—CYP3A4—Vincristine—hematologic cancer	0.00355	0.00566	CbGbCtD
Zaleplon—CYP3A4—Etoposide—hematologic cancer	0.00325	0.00519	CbGbCtD
Zaleplon—CYP3A4—Dexamethasone—hematologic cancer	0.00267	0.00427	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—hematologic cancer	0.00222	0.00354	CbGbCtD
Zaleplon—TSPO—hematopoietic system—hematologic cancer	0.000312	0.0775	CbGeAlD
Zaleplon—AOX1—gonad—hematologic cancer	0.000278	0.0689	CbGeAlD
Zaleplon—TSPO—gonad—hematologic cancer	0.000237	0.0589	CbGeAlD
Zaleplon—GABRB3—gonad—hematologic cancer	0.000215	0.0535	CbGeAlD
Zaleplon—GABRB2—lung—hematologic cancer	0.000214	0.0532	CbGeAlD
Zaleplon—AOX1—lung—hematologic cancer	0.000212	0.0527	CbGeAlD
Zaleplon—TSPO—blood—hematologic cancer	0.000207	0.0513	CbGeAlD
Zaleplon—GABRB2—testis—hematologic cancer	0.000202	0.0502	CbGeAlD
Zaleplon—AOX1—testis—hematologic cancer	0.0002	0.0497	CbGeAlD
Zaleplon—TSPO—bone marrow—hematologic cancer	0.0002	0.0497	CbGeAlD
Zaleplon—CYP3A5—hematopoietic system—hematologic cancer	0.000193	0.048	CbGeAlD
Zaleplon—TSPO—lung—hematologic cancer	0.000181	0.045	CbGeAlD
Zaleplon—TSPO—testis—hematologic cancer	0.000171	0.0424	CbGeAlD
Zaleplon—GABRB3—lung—hematologic cancer	0.000164	0.0408	CbGeAlD
Zaleplon—GABRB3—testis—hematologic cancer	0.000155	0.0385	CbGeAlD
Zaleplon—AOX1—lymph node—hematologic cancer	0.000145	0.036	CbGeAlD
Zaleplon—CYP3A4—hematopoietic system—hematologic cancer	0.000145	0.036	CbGeAlD
Zaleplon—GABRA2—lymph node—hematologic cancer	0.000134	0.0332	CbGeAlD
Zaleplon—CYP3A5—blood—hematologic cancer	0.000128	0.0318	CbGeAlD
Zaleplon—TSPO—lymph node—hematologic cancer	0.000124	0.0308	CbGeAlD
Zaleplon—CYP3A5—lung—hematologic cancer	0.000112	0.0279	CbGeAlD
Zaleplon—CYP3A4—blood—hematologic cancer	9.6e-05	0.0239	CbGeAlD
Zaleplon—Eye disorder—Epirubicin—hematologic cancer	2.52e-05	7.4e-05	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—hematologic cancer	2.51e-05	7.38e-05	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—hematologic cancer	2.51e-05	7.37e-05	CcSEcCtD
Zaleplon—Headache—Gemcitabine—hematologic cancer	2.51e-05	7.36e-05	CcSEcCtD
Zaleplon—Nausea—Vincristine—hematologic cancer	2.51e-05	7.36e-05	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—hematologic cancer	2.48e-05	7.29e-05	CcSEcCtD
Zaleplon—Dyspepsia—Dexamethasone—hematologic cancer	2.48e-05	7.27e-05	CcSEcCtD
Zaleplon—Dyspepsia—Betamethasone—hematologic cancer	2.48e-05	7.27e-05	CcSEcCtD
Zaleplon—Urticaria—Triamcinolone—hematologic cancer	2.46e-05	7.23e-05	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—hematologic cancer	2.46e-05	7.22e-05	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—hematologic cancer	2.46e-05	7.21e-05	CcSEcCtD
Zaleplon—Asthenia—Etoposide—hematologic cancer	2.45e-05	7.2e-05	CcSEcCtD
Zaleplon—Body temperature increased—Triamcinolone—hematologic cancer	2.45e-05	7.2e-05	CcSEcCtD
Zaleplon—Oedema—Prednisone—hematologic cancer	2.45e-05	7.19e-05	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisone—hematologic cancer	2.45e-05	7.19e-05	CcSEcCtD
Zaleplon—Decreased appetite—Betamethasone—hematologic cancer	2.44e-05	7.18e-05	CcSEcCtD
Zaleplon—Decreased appetite—Dexamethasone—hematologic cancer	2.44e-05	7.18e-05	CcSEcCtD
Zaleplon—Nausea—Mitoxantrone—hematologic cancer	2.44e-05	7.17e-05	CcSEcCtD
Zaleplon—Nausea—Irinotecan—hematologic cancer	2.44e-05	7.17e-05	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—hematologic cancer	2.43e-05	7.15e-05	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.43e-05	7.13e-05	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.43e-05	7.13e-05	CcSEcCtD
Zaleplon—Back pain—Methotrexate—hematologic cancer	2.43e-05	7.12e-05	CcSEcCtD
Zaleplon—Chills—Epirubicin—hematologic cancer	2.42e-05	7.1e-05	CcSEcCtD
Zaleplon—Pruritus—Etoposide—hematologic cancer	2.42e-05	7.1e-05	CcSEcCtD
Zaleplon—Shock—Prednisone—hematologic cancer	2.41e-05	7.08e-05	CcSEcCtD
Zaleplon—Pain—Dexamethasone—hematologic cancer	2.4e-05	7.06e-05	CcSEcCtD
Zaleplon—Pain—Betamethasone—hematologic cancer	2.4e-05	7.06e-05	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—hematologic cancer	2.4e-05	7.06e-05	CcSEcCtD
Zaleplon—Nervous system disorder—Prednisone—hematologic cancer	2.4e-05	7.05e-05	CcSEcCtD
Zaleplon—Tachycardia—Prednisone—hematologic cancer	2.39e-05	7.02e-05	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—hematologic cancer	2.38e-05	7e-05	CcSEcCtD
Zaleplon—Skin disorder—Prednisone—hematologic cancer	2.38e-05	6.99e-05	CcSEcCtD
Zaleplon—Nausea—Gemcitabine—hematologic cancer	2.38e-05	6.98e-05	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisone—hematologic cancer	2.37e-05	6.95e-05	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—hematologic cancer	2.36e-05	6.94e-05	CcSEcCtD
Zaleplon—Rash—Cisplatin—hematologic cancer	2.35e-05	6.91e-05	CcSEcCtD
Zaleplon—Dermatitis—Cisplatin—hematologic cancer	2.35e-05	6.9e-05	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—hematologic cancer	2.35e-05	6.89e-05	CcSEcCtD
Zaleplon—Anorexia—Prednisone—hematologic cancer	2.33e-05	6.86e-05	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—hematologic cancer	2.33e-05	6.85e-05	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—hematologic cancer	2.33e-05	6.83e-05	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—hematologic cancer	2.33e-05	6.83e-05	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—hematologic cancer	2.32e-05	6.81e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Betamethasone—hematologic cancer	2.32e-05	6.81e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Dexamethasone—hematologic cancer	2.32e-05	6.81e-05	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—hematologic cancer	2.31e-05	6.79e-05	CcSEcCtD
Zaleplon—Tension—Epirubicin—hematologic cancer	2.3e-05	6.76e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.3e-05	6.75e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Betamethasone—hematologic cancer	2.3e-05	6.75e-05	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—hematologic cancer	2.3e-05	6.75e-05	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—hematologic cancer	2.28e-05	6.69e-05	CcSEcCtD
Zaleplon—Back pain—Epirubicin—hematologic cancer	2.27e-05	6.67e-05	CcSEcCtD
Zaleplon—Malaise—Methotrexate—hematologic cancer	2.26e-05	6.64e-05	CcSEcCtD
Zaleplon—Dizziness—Etoposide—hematologic cancer	2.26e-05	6.64e-05	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—hematologic cancer	2.25e-05	6.62e-05	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—hematologic cancer	2.25e-05	6.62e-05	CcSEcCtD
Zaleplon—Chills—Doxorubicin—hematologic cancer	2.24e-05	6.57e-05	CcSEcCtD
Zaleplon—Urticaria—Betamethasone—hematologic cancer	2.23e-05	6.56e-05	CcSEcCtD
Zaleplon—Urticaria—Dexamethasone—hematologic cancer	2.23e-05	6.56e-05	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.23e-05	6.55e-05	CcSEcCtD
Zaleplon—Dizziness—Prednisolone—hematologic cancer	2.23e-05	6.55e-05	CcSEcCtD
Zaleplon—Asthenia—Triamcinolone—hematologic cancer	2.22e-05	6.53e-05	CcSEcCtD
Zaleplon—Abdominal pain—Betamethasone—hematologic cancer	2.22e-05	6.53e-05	CcSEcCtD
Zaleplon—Body temperature increased—Dexamethasone—hematologic cancer	2.22e-05	6.53e-05	CcSEcCtD
Zaleplon—Abdominal pain—Dexamethasone—hematologic cancer	2.22e-05	6.53e-05	CcSEcCtD
Zaleplon—Body temperature increased—Betamethasone—hematologic cancer	2.22e-05	6.53e-05	CcSEcCtD
Zaleplon—Nausea—Cisplatin—hematologic cancer	2.22e-05	6.51e-05	CcSEcCtD
Zaleplon—Insomnia—Prednisone—hematologic cancer	2.21e-05	6.51e-05	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—hematologic cancer	2.2e-05	6.47e-05	CcSEcCtD
Zaleplon—Paraesthesia—Prednisone—hematologic cancer	2.2e-05	6.46e-05	CcSEcCtD
Zaleplon—Pruritus—Triamcinolone—hematologic cancer	2.19e-05	6.44e-05	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—hematologic cancer	2.19e-05	6.42e-05	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—hematologic cancer	2.18e-05	6.4e-05	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—hematologic cancer	2.17e-05	6.38e-05	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—hematologic cancer	2.17e-05	6.37e-05	CcSEcCtD
Zaleplon—Agitation—Epirubicin—hematologic cancer	2.16e-05	6.33e-05	CcSEcCtD
Zaleplon—Dyspepsia—Prednisone—hematologic cancer	2.16e-05	6.33e-05	CcSEcCtD
Zaleplon—Rash—Etoposide—hematologic cancer	2.15e-05	6.33e-05	CcSEcCtD
Zaleplon—Dermatitis—Etoposide—hematologic cancer	2.15e-05	6.32e-05	CcSEcCtD
Zaleplon—Headache—Etoposide—hematologic cancer	2.14e-05	6.29e-05	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—hematologic cancer	2.14e-05	6.28e-05	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—hematologic cancer	2.13e-05	6.27e-05	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—hematologic cancer	2.13e-05	6.27e-05	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—hematologic cancer	2.13e-05	6.27e-05	CcSEcCtD
Zaleplon—Tension—Doxorubicin—hematologic cancer	2.13e-05	6.26e-05	CcSEcCtD
Zaleplon—Decreased appetite—Prednisone—hematologic cancer	2.13e-05	6.25e-05	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—hematologic cancer	2.13e-05	6.25e-05	CcSEcCtD
Zaleplon—Rash—Prednisolone—hematologic cancer	2.12e-05	6.24e-05	CcSEcCtD
Zaleplon—Dermatitis—Prednisolone—hematologic cancer	2.12e-05	6.24e-05	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.12e-05	6.23e-05	CcSEcCtD
Zaleplon—Malaise—Epirubicin—hematologic cancer	2.12e-05	6.22e-05	CcSEcCtD
Zaleplon—Headache—Prednisolone—hematologic cancer	2.11e-05	6.2e-05	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—hematologic cancer	2.11e-05	6.2e-05	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—hematologic cancer	2.11e-05	6.19e-05	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—hematologic cancer	2.11e-05	6.19e-05	CcSEcCtD
Zaleplon—Syncope—Epirubicin—hematologic cancer	2.1e-05	6.18e-05	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—hematologic cancer	2.1e-05	6.17e-05	CcSEcCtD
Zaleplon—Constipation—Prednisone—hematologic cancer	2.09e-05	6.15e-05	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—hematologic cancer	2.07e-05	6.09e-05	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—hematologic cancer	2.06e-05	6.06e-05	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—hematologic cancer	2.06e-05	6.06e-05	CcSEcCtD
Zaleplon—Dizziness—Triamcinolone—hematologic cancer	2.05e-05	6.02e-05	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—hematologic cancer	2.05e-05	6.01e-05	CcSEcCtD
Zaleplon—Nausea—Etoposide—hematologic cancer	2.03e-05	5.96e-05	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—hematologic cancer	2.03e-05	5.95e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Prednisone—hematologic cancer	2.02e-05	5.93e-05	CcSEcCtD
Zaleplon—Asthenia—Betamethasone—hematologic cancer	2.02e-05	5.93e-05	CcSEcCtD
Zaleplon—Asthenia—Dexamethasone—hematologic cancer	2.02e-05	5.93e-05	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—hematologic cancer	2.01e-05	5.92e-05	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—hematologic cancer	2.01e-05	5.9e-05	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—hematologic cancer	2.01e-05	5.89e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Prednisone—hematologic cancer	2e-05	5.88e-05	CcSEcCtD
Zaleplon—Nausea—Prednisolone—hematologic cancer	2e-05	5.88e-05	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—hematologic cancer	2e-05	5.87e-05	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—hematologic cancer	2e-05	5.87e-05	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—hematologic cancer	2e-05	5.87e-05	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—hematologic cancer	2e-05	5.86e-05	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—hematologic cancer	1.99e-05	5.85e-05	CcSEcCtD
Zaleplon—Pruritus—Dexamethasone—hematologic cancer	1.99e-05	5.84e-05	CcSEcCtD
Zaleplon—Pruritus—Betamethasone—hematologic cancer	1.99e-05	5.84e-05	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—hematologic cancer	1.99e-05	5.84e-05	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.98e-05	5.83e-05	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—hematologic cancer	1.98e-05	5.81e-05	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—hematologic cancer	1.97e-05	5.8e-05	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—hematologic cancer	1.96e-05	5.75e-05	CcSEcCtD
Zaleplon—Rash—Triamcinolone—hematologic cancer	1.95e-05	5.74e-05	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—hematologic cancer	1.95e-05	5.74e-05	CcSEcCtD
Zaleplon—Dermatitis—Triamcinolone—hematologic cancer	1.95e-05	5.73e-05	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—hematologic cancer	1.95e-05	5.73e-05	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—hematologic cancer	1.95e-05	5.73e-05	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—hematologic cancer	1.95e-05	5.72e-05	CcSEcCtD
Zaleplon—Urticaria—Prednisone—hematologic cancer	1.95e-05	5.71e-05	CcSEcCtD
Zaleplon—Headache—Triamcinolone—hematologic cancer	1.94e-05	5.7e-05	CcSEcCtD
Zaleplon—Body temperature increased—Prednisone—hematologic cancer	1.94e-05	5.69e-05	CcSEcCtD
Zaleplon—Abdominal pain—Prednisone—hematologic cancer	1.94e-05	5.69e-05	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—hematologic cancer	1.93e-05	5.67e-05	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—hematologic cancer	1.92e-05	5.64e-05	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—hematologic cancer	1.92e-05	5.63e-05	CcSEcCtD
Zaleplon—Oedema—Epirubicin—hematologic cancer	1.92e-05	5.63e-05	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—hematologic cancer	1.91e-05	5.62e-05	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—hematologic cancer	1.91e-05	5.61e-05	CcSEcCtD
Zaleplon—Shock—Epirubicin—hematologic cancer	1.88e-05	5.53e-05	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—hematologic cancer	1.88e-05	5.52e-05	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—hematologic cancer	1.87e-05	5.51e-05	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—hematologic cancer	1.87e-05	5.49e-05	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.86e-05	5.48e-05	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—hematologic cancer	1.86e-05	5.46e-05	CcSEcCtD
Zaleplon—Dizziness—Betamethasone—hematologic cancer	1.86e-05	5.46e-05	CcSEcCtD
Zaleplon—Dizziness—Dexamethasone—hematologic cancer	1.86e-05	5.46e-05	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—hematologic cancer	1.85e-05	5.44e-05	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—hematologic cancer	1.85e-05	5.44e-05	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—hematologic cancer	1.85e-05	5.43e-05	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—hematologic cancer	1.85e-05	5.43e-05	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—hematologic cancer	1.85e-05	5.43e-05	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—hematologic cancer	1.84e-05	5.41e-05	CcSEcCtD
Zaleplon—Nausea—Triamcinolone—hematologic cancer	1.84e-05	5.41e-05	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—hematologic cancer	1.84e-05	5.4e-05	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.84e-05	5.39e-05	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—hematologic cancer	1.83e-05	5.36e-05	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—hematologic cancer	1.83e-05	5.36e-05	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—hematologic cancer	1.82e-05	5.36e-05	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—hematologic cancer	1.82e-05	5.34e-05	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—hematologic cancer	1.81e-05	5.31e-05	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—hematologic cancer	1.8e-05	5.29e-05	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—hematologic cancer	1.79e-05	5.26e-05	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—hematologic cancer	1.79e-05	5.25e-05	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—hematologic cancer	1.78e-05	5.23e-05	CcSEcCtD
Zaleplon—Rash—Dexamethasone—hematologic cancer	1.77e-05	5.21e-05	CcSEcCtD
Zaleplon—Rash—Betamethasone—hematologic cancer	1.77e-05	5.21e-05	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—hematologic cancer	1.77e-05	5.21e-05	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—hematologic cancer	1.77e-05	5.21e-05	CcSEcCtD
Zaleplon—Dermatitis—Betamethasone—hematologic cancer	1.77e-05	5.2e-05	CcSEcCtD
Zaleplon—Dermatitis—Dexamethasone—hematologic cancer	1.77e-05	5.2e-05	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.77e-05	5.19e-05	CcSEcCtD
Zaleplon—Headache—Betamethasone—hematologic cancer	1.76e-05	5.17e-05	CcSEcCtD
Zaleplon—Headache—Dexamethasone—hematologic cancer	1.76e-05	5.17e-05	CcSEcCtD
Zaleplon—Asthenia—Prednisone—hematologic cancer	1.76e-05	5.16e-05	CcSEcCtD
Zaleplon—Pain—Methotrexate—hematologic cancer	1.75e-05	5.14e-05	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.74e-05	5.13e-05	CcSEcCtD
Zaleplon—Shock—Doxorubicin—hematologic cancer	1.74e-05	5.12e-05	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—hematologic cancer	1.74e-05	5.1e-05	CcSEcCtD
Zaleplon—Pruritus—Prednisone—hematologic cancer	1.73e-05	5.09e-05	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—hematologic cancer	1.73e-05	5.09e-05	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—hematologic cancer	1.73e-05	5.08e-05	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—hematologic cancer	1.72e-05	5.06e-05	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—hematologic cancer	1.72e-05	5.05e-05	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—hematologic cancer	1.71e-05	5.03e-05	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—hematologic cancer	1.71e-05	5.02e-05	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—hematologic cancer	1.7e-05	5e-05	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—hematologic cancer	1.69e-05	4.96e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—hematologic cancer	1.69e-05	4.95e-05	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—hematologic cancer	1.69e-05	4.95e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—hematologic cancer	1.67e-05	4.92e-05	CcSEcCtD
Zaleplon—Nausea—Betamethasone—hematologic cancer	1.67e-05	4.91e-05	CcSEcCtD
Zaleplon—Nausea—Dexamethasone—hematologic cancer	1.67e-05	4.91e-05	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—hematologic cancer	1.66e-05	4.89e-05	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—hematologic cancer	1.66e-05	4.86e-05	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.65e-05	4.86e-05	CcSEcCtD
Zaleplon—Constipation—Epirubicin—hematologic cancer	1.64e-05	4.81e-05	CcSEcCtD
Zaleplon—Pain—Epirubicin—hematologic cancer	1.64e-05	4.81e-05	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—hematologic cancer	1.63e-05	4.78e-05	CcSEcCtD
Zaleplon—Dizziness—Prednisone—hematologic cancer	1.62e-05	4.76e-05	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—hematologic cancer	1.62e-05	4.75e-05	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—hematologic cancer	1.62e-05	4.75e-05	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.61e-05	4.74e-05	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—hematologic cancer	1.6e-05	4.71e-05	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—hematologic cancer	1.59e-05	4.67e-05	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—hematologic cancer	1.58e-05	4.64e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—hematologic cancer	1.58e-05	4.64e-05	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—hematologic cancer	1.58e-05	4.63e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—hematologic cancer	1.57e-05	4.6e-05	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—hematologic cancer	1.56e-05	4.58e-05	CcSEcCtD
Zaleplon—Rash—Prednisone—hematologic cancer	1.54e-05	4.54e-05	CcSEcCtD
Zaleplon—Dermatitis—Prednisone—hematologic cancer	1.54e-05	4.53e-05	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—hematologic cancer	1.54e-05	4.52e-05	CcSEcCtD
Zaleplon—GABRB3—BDNF signaling pathway—HRAS—hematologic cancer	1.53e-05	0.000521	CbGpPWpGaD
Zaleplon—Headache—Prednisone—hematologic cancer	1.53e-05	4.51e-05	CcSEcCtD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.53e-05	0.00052	CbGpPWpGaD
Zaleplon—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.53e-05	4.49e-05	CcSEcCtD
Zaleplon—AOX1—Metabolism—HSP90AA1—hematologic cancer	1.53e-05	0.000519	CbGpPWpGaD
Zaleplon—Urticaria—Epirubicin—hematologic cancer	1.52e-05	4.47e-05	CcSEcCtD
Zaleplon—AOX1—Disease—CD86—hematologic cancer	1.52e-05	0.000515	CbGpPWpGaD
Zaleplon—Constipation—Doxorubicin—hematologic cancer	1.52e-05	4.45e-05	CcSEcCtD
Zaleplon—Pain—Doxorubicin—hematologic cancer	1.52e-05	4.45e-05	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—hematologic cancer	1.51e-05	4.45e-05	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—hematologic cancer	1.51e-05	4.45e-05	CcSEcCtD
Zaleplon—AOX1—Disease—HES1—hematologic cancer	1.5e-05	0.000508	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HDC—hematologic cancer	1.5e-05	0.000507	CbGpPWpGaD
Zaleplon—AOX1—Disease—NCOR1—hematologic cancer	1.49e-05	0.000505	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGF1—hematologic cancer	1.47e-05	0.000499	CbGpPWpGaD
Zaleplon—Asthenia—Methotrexate—hematologic cancer	1.47e-05	4.31e-05	CcSEcCtD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.47e-05	0.000497	CbGpPWpGaD
Zaleplon—Feeling abnormal—Doxorubicin—hematologic cancer	1.46e-05	4.29e-05	CcSEcCtD
Zaleplon—Nausea—Prednisone—hematologic cancer	1.45e-05	4.27e-05	CcSEcCtD
Zaleplon—AOX1—Disease—FOXO1—hematologic cancer	1.45e-05	0.000492	CbGpPWpGaD
Zaleplon—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.45e-05	4.26e-05	CcSEcCtD
Zaleplon—AOX1—Disease—PDGFRB—hematologic cancer	1.45e-05	0.000491	CbGpPWpGaD
Zaleplon—Pruritus—Methotrexate—hematologic cancer	1.45e-05	4.25e-05	CcSEcCtD
Zaleplon—CYP3A7—Metabolism—FHL2—hematologic cancer	1.43e-05	0.000487	CbGpPWpGaD
Zaleplon—AOX1—Disease—PDGFRA—hematologic cancer	1.43e-05	0.000484	CbGpPWpGaD
Zaleplon—AOX1—Disease—JAK1—hematologic cancer	1.42e-05	0.000482	CbGpPWpGaD
Zaleplon—AOX1—Disease—PRKCG—hematologic cancer	1.42e-05	0.000482	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—MDM2—hematologic cancer	1.41e-05	0.00048	CbGpPWpGaD
Zaleplon—Urticaria—Doxorubicin—hematologic cancer	1.41e-05	4.14e-05	CcSEcCtD
Zaleplon—CYP3A7—Metabolism—AGRN—hematologic cancer	1.41e-05	0.000477	CbGpPWpGaD
Zaleplon—Abdominal pain—Doxorubicin—hematologic cancer	1.4e-05	4.11e-05	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—hematologic cancer	1.4e-05	4.11e-05	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—hematologic cancer	1.37e-05	4.04e-05	CcSEcCtD
Zaleplon—CYP3A5—Metabolism—CDA—hematologic cancer	1.37e-05	0.000464	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTP1—hematologic cancer	1.36e-05	0.00046	CbGpPWpGaD
Zaleplon—Pruritus—Epirubicin—hematologic cancer	1.36e-05	3.98e-05	CcSEcCtD
Zaleplon—GABRB3—BDNF signaling pathway—AKT1—hematologic cancer	1.35e-05	0.00046	CbGpPWpGaD
Zaleplon—Dizziness—Methotrexate—hematologic cancer	1.35e-05	3.98e-05	CcSEcCtD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	1.35e-05	0.000457	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.34e-05	0.000454	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—IDH2—hematologic cancer	1.33e-05	0.000452	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMMR—hematologic cancer	1.33e-05	0.000452	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PC—hematologic cancer	1.32e-05	0.000447	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTHFR—hematologic cancer	1.32e-05	0.000446	CbGpPWpGaD
Zaleplon—AOX1—Disease—HLA-A—hematologic cancer	1.31e-05	0.000445	CbGpPWpGaD
Zaleplon—AOX1—Disease—TERT—hematologic cancer	1.31e-05	0.000445	CbGpPWpGaD
Zaleplon—Rash—Methotrexate—hematologic cancer	1.29e-05	3.79e-05	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—hematologic cancer	1.29e-05	3.79e-05	CcSEcCtD
Zaleplon—AOX1—Metabolism—ABCB1—hematologic cancer	1.28e-05	0.000436	CbGpPWpGaD
Zaleplon—Headache—Methotrexate—hematologic cancer	1.28e-05	3.77e-05	CcSEcCtD
Zaleplon—AOX1—Disease—PDGFB—hematologic cancer	1.28e-05	0.000434	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GBA—hematologic cancer	1.27e-05	0.000431	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC35B2—hematologic cancer	1.27e-05	0.000431	CbGpPWpGaD
Zaleplon—Asthenia—Doxorubicin—hematologic cancer	1.27e-05	3.73e-05	CcSEcCtD
Zaleplon—GABRB2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.27e-05	0.00043	CbGpPWpGaD
Zaleplon—Dizziness—Epirubicin—hematologic cancer	1.27e-05	3.72e-05	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—hematologic cancer	1.25e-05	3.68e-05	CcSEcCtD
Zaleplon—CYP3A7—Metabolism—ARNTL—hematologic cancer	1.25e-05	0.000425	CbGpPWpGaD
Zaleplon—AOX1—Disease—TSC2—hematologic cancer	1.25e-05	0.000425	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTM1—hematologic cancer	1.25e-05	0.000423	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NCOR1—hematologic cancer	1.25e-05	0.000423	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CA9—hematologic cancer	1.22e-05	0.000414	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ACP5—hematologic cancer	1.22e-05	0.000414	CbGpPWpGaD
Zaleplon—Nausea—Methotrexate—hematologic cancer	1.22e-05	3.57e-05	CcSEcCtD
Zaleplon—Rash—Epirubicin—hematologic cancer	1.21e-05	3.55e-05	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—hematologic cancer	1.21e-05	3.54e-05	CcSEcCtD
Zaleplon—AOX1—Disease—FGFR3—hematologic cancer	1.2e-05	0.000409	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOR2—hematologic cancer	1.2e-05	0.000408	CbGpPWpGaD
Zaleplon—Headache—Epirubicin—hematologic cancer	1.2e-05	3.52e-05	CcSEcCtD
Zaleplon—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.2e-05	0.000406	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.19e-05	0.000403	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.18e-05	0.000401	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.18e-05	0.000401	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.18e-05	0.0004	CbGpPWpGaD
Zaleplon—Dizziness—Doxorubicin—hematologic cancer	1.17e-05	3.44e-05	CcSEcCtD
Zaleplon—CYP3A5—Metabolism—MTAP—hematologic cancer	1.16e-05	0.000395	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.16e-05	0.000393	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—IDH1—hematologic cancer	1.15e-05	0.000389	CbGpPWpGaD
Zaleplon—AOX1—Disease—BAD—hematologic cancer	1.14e-05	0.000387	CbGpPWpGaD
Zaleplon—Nausea—Epirubicin—hematologic cancer	1.14e-05	3.34e-05	CcSEcCtD
Zaleplon—CYP3A7—Metabolism—GSTO1—hematologic cancer	1.13e-05	0.000385	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TXN—hematologic cancer	1.13e-05	0.000385	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCC3—hematologic cancer	1.13e-05	0.000385	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOTCH1—hematologic cancer	1.13e-05	0.000384	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.12e-05	0.00038	CbGpPWpGaD
Zaleplon—Rash—Doxorubicin—hematologic cancer	1.12e-05	3.28e-05	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—hematologic cancer	1.12e-05	3.28e-05	CcSEcCtD
Zaleplon—Headache—Doxorubicin—hematologic cancer	1.11e-05	3.26e-05	CcSEcCtD
Zaleplon—CYP3A7—Metabolism—SPHK1—hematologic cancer	1.11e-05	0.000376	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD80—hematologic cancer	1.11e-05	0.000376	CbGpPWpGaD
Zaleplon—AOX1—Disease—KIT—hematologic cancer	1.11e-05	0.000375	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—MTHFR—hematologic cancer	1.1e-05	0.000374	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.1e-05	0.000373	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTPN11—hematologic cancer	1.09e-05	0.000368	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.09e-05	0.000368	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—UGT1A1—hematologic cancer	1.07e-05	0.000362	CbGpPWpGaD
Zaleplon—Nausea—Doxorubicin—hematologic cancer	1.05e-05	3.09e-05	CcSEcCtD
Zaleplon—AOX1—Disease—CREB1—hematologic cancer	1.05e-05	0.000357	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.05e-05	0.000356	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.05e-05	0.000356	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.04e-05	0.000354	CbGpPWpGaD
Zaleplon—AOX1—Disease—BRAF—hematologic cancer	1.04e-05	0.000353	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC22A1—hematologic cancer	1.04e-05	0.000352	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CRABP1—hematologic cancer	1.04e-05	0.000352	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—FHL2—hematologic cancer	1.04e-05	0.000352	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6R—hematologic cancer	1.03e-05	0.000348	CbGpPWpGaD
Zaleplon—AOX1—Disease—CREBBP—hematologic cancer	1.02e-05	0.000348	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.02e-05	0.000347	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AGRN—hematologic cancer	1.02e-05	0.000345	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.01e-05	0.000344	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALOX5—hematologic cancer	1.01e-05	0.000343	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	9.82e-06	0.000333	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NUP98—hematologic cancer	9.79e-06	0.000332	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAP2K1—hematologic cancer	9.78e-06	0.000332	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—hematologic cancer	9.76e-06	0.000331	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CD—hematologic cancer	9.72e-06	0.00033	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—HRAS—hematologic cancer	9.71e-06	0.000329	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—IDH2—hematologic cancer	9.64e-06	0.000327	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMMR—hematologic cancer	9.64e-06	0.000327	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	9.58e-06	0.000325	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ADCY7—hematologic cancer	9.5e-06	0.000322	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOA3—hematologic cancer	9.5e-06	0.000322	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NUP214—hematologic cancer	9.43e-06	0.00032	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGF2—hematologic cancer	9.3e-06	0.000316	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CG—hematologic cancer	9.26e-06	0.000314	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTR—hematologic cancer	9.24e-06	0.000314	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCG2—hematologic cancer	9.24e-06	0.000314	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3R1—hematologic cancer	9.18e-06	0.000311	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FTCD—hematologic cancer	9.17e-06	0.000311	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PHYH—hematologic cancer	9.17e-06	0.000311	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GMPS—hematologic cancer	9.17e-06	0.000311	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—HRAS—hematologic cancer	9.1e-06	0.000309	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ENO2—hematologic cancer	9.06e-06	0.000307	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ARNTL—hematologic cancer	9.06e-06	0.000307	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—HRAS—hematologic cancer	9.04e-06	0.000307	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.95e-06	0.000304	CbGpPWpGaD
Zaleplon—AOX1—Disease—JAK2—hematologic cancer	8.92e-06	0.000303	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—HRAS—hematologic cancer	8.88e-06	0.000301	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ACP5—hematologic cancer	8.81e-06	0.000299	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CA9—hematologic cancer	8.81e-06	0.000299	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTT1—hematologic cancer	8.79e-06	0.000298	CbGpPWpGaD
Zaleplon—AOX1—Disease—MDM2—hematologic cancer	8.71e-06	0.000295	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOR2—hematologic cancer	8.7e-06	0.000295	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SDC1—hematologic cancer	8.59e-06	0.000291	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CREBBP—hematologic cancer	8.58e-06	0.000291	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTOR—hematologic cancer	8.47e-06	0.000287	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CB—hematologic cancer	8.47e-06	0.000287	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD4—hematologic cancer	8.45e-06	0.000287	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SMPD3—hematologic cancer	8.39e-06	0.000285	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.38e-06	0.000284	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—IDH1—hematologic cancer	8.29e-06	0.000281	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TXN—hematologic cancer	8.19e-06	0.000278	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTO1—hematologic cancer	8.19e-06	0.000278	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCC3—hematologic cancer	8.19e-06	0.000278	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CD—hematologic cancer	8.14e-06	0.000276	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—hematologic cancer	8.03e-06	0.000273	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SPHK1—hematologic cancer	8.02e-06	0.000272	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1B—hematologic cancer	7.95e-06	0.00027	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—HRAS—hematologic cancer	7.76e-06	0.000263	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—UGT1A1—hematologic cancer	7.7e-06	0.000261	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3R1—hematologic cancer	7.68e-06	0.000261	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CRABP1—hematologic cancer	7.49e-06	0.000254	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC22A1—hematologic cancer	7.49e-06	0.000254	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1A—hematologic cancer	7.34e-06	0.000249	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—DCK—hematologic cancer	7.33e-06	0.000249	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ASNS—hematologic cancer	7.33e-06	0.000249	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.33e-06	0.000249	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTEN—hematologic cancer	7.32e-06	0.000248	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NQO1—hematologic cancer	7.3e-06	0.000248	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CD44—hematologic cancer	7.3e-06	0.000248	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALOX5—hematologic cancer	7.3e-06	0.000248	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CB—hematologic cancer	7.09e-06	0.000241	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NUP98—hematologic cancer	7.07e-06	0.00024	CbGpPWpGaD
Zaleplon—AOX1—Disease—EP300—hematologic cancer	6.98e-06	0.000237	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HDC—hematologic cancer	6.95e-06	0.000236	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYCS—hematologic cancer	6.91e-06	0.000235	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	6.87e-06	0.000233	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADCY7—hematologic cancer	6.87e-06	0.000233	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOA3—hematologic cancer	6.87e-06	0.000233	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NUP214—hematologic cancer	6.82e-06	0.000231	CbGpPWpGaD
Zaleplon—AOX1—Disease—SRC—hematologic cancer	6.79e-06	0.00023	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCG2—hematologic cancer	6.68e-06	0.000227	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTR—hematologic cancer	6.68e-06	0.000227	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ENO2—hematologic cancer	6.55e-06	0.000222	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—hematologic cancer	6.55e-06	0.000222	CbGpPWpGaD
Zaleplon—AOX1—Disease—NRAS—hematologic cancer	6.53e-06	0.000222	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CDA—hematologic cancer	6.36e-06	0.000216	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTT1—hematologic cancer	6.35e-06	0.000216	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAPK3—hematologic cancer	6.25e-06	0.000212	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SDC1—hematologic cancer	6.21e-06	0.000211	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTEN—hematologic cancer	6.13e-06	0.000208	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PC—hematologic cancer	6.12e-06	0.000208	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—hematologic cancer	6.09e-06	0.000207	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—hematologic cancer	6.08e-06	0.000206	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFB1—hematologic cancer	6.07e-06	0.000206	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GBA—hematologic cancer	5.91e-06	0.000201	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.91e-06	0.000201	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—EP300—hematologic cancer	5.85e-06	0.000198	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCB1—hematologic cancer	5.77e-06	0.000196	CbGpPWpGaD
Zaleplon—AOX1—Disease—KRAS—hematologic cancer	5.62e-06	0.000191	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOR1—hematologic cancer	5.6e-06	0.00019	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—hematologic cancer	5.6e-06	0.00019	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTAP—hematologic cancer	5.41e-06	0.000183	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CD44—hematologic cancer	5.28e-06	0.000179	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NQO1—hematologic cancer	5.28e-06	0.000179	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CA—hematologic cancer	5.16e-06	0.000175	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYCS—hematologic cancer	5e-06	0.00017	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.96e-06	0.000168	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTHFR—hematologic cancer	4.95e-06	0.000168	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FHL2—hematologic cancer	4.82e-06	0.000164	CbGpPWpGaD
Zaleplon—AOX1—Disease—HRAS—hematologic cancer	4.78e-06	0.000162	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AGRN—hematologic cancer	4.73e-06	0.00016	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—hematologic cancer	4.57e-06	0.000155	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMMR—hematologic cancer	4.48e-06	0.000152	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—IDH2—hematologic cancer	4.48e-06	0.000152	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.4e-06	0.000149	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CA—hematologic cancer	4.32e-06	0.000147	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—hematologic cancer	4.22e-06	0.000143	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.21e-06	0.000143	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.17e-06	0.000141	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CG—hematologic cancer	4.16e-06	0.000141	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CA9—hematologic cancer	4.1e-06	0.000139	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ACP5—hematologic cancer	4.1e-06	0.000139	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.05e-06	0.000137	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.05e-06	0.000137	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.04e-06	0.000137	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.85e-06	0.000131	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—IDH1—hematologic cancer	3.85e-06	0.000131	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.81e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.81e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TXN—hematologic cancer	3.81e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.73e-06	0.000126	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CD—hematologic cancer	3.65e-06	0.000124	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—hematologic cancer	3.61e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.58e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.58e-06	0.000121	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—hematologic cancer	3.53e-06	0.00012	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.48e-06	0.000118	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.48e-06	0.000118	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.45e-06	0.000117	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.4e-06	0.000115	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NUP98—hematologic cancer	3.29e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.19e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.19e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.19e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NUP214—hematologic cancer	3.17e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.11e-06	0.000105	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTR—hematologic cancer	3.11e-06	0.000105	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ENO2—hematologic cancer	3.05e-06	0.000103	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.01e-06	0.000102	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.95e-06	0.0001	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SDC1—hematologic cancer	2.89e-06	9.8e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.79e-06	9.45e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTEN—hematologic cancer	2.75e-06	9.34e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.64e-06	8.96e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—EP300—hematologic cancer	2.63e-06	8.91e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—hematologic cancer	2.61e-06	8.85e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.49e-06	8.46e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CD44—hematologic cancer	2.45e-06	8.33e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NQO1—hematologic cancer	2.45e-06	8.33e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYCS—hematologic cancer	2.32e-06	7.88e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.31e-06	7.83e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.3e-06	7.81e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.05e-06	6.95e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTEN—hematologic cancer	1.99e-06	6.75e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.94e-06	6.59e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.94e-06	6.58e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—EP300—hematologic cancer	1.9e-06	6.44e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.88e-06	6.38e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.88e-06	6.38e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.66e-06	5.64e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—hematologic cancer	1.59e-06	5.38e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.4e-06	4.76e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.4e-06	4.74e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.3e-06	4.39e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.23e-06	4.17e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—hematologic cancer	1.21e-06	4.11e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.16e-06	3.93e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—hematologic cancer	1.15e-06	3.89e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.07e-06	3.63e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTEN—hematologic cancer	9.25e-07	3.14e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—EP300—hematologic cancer	8.82e-07	2.99e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.53e-07	2.21e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—hematologic cancer	5.33e-07	1.81e-05	CbGpPWpGaD
